LIAN logo

LianBio (LIAN) Stock

Profile

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

01 November 2021

Indexes:

Not included

Description:

LianBio is a biopharmaceutical company focused on developing and commercializing innovative medicines. It aims to address unmet medical needs in China and other markets by partnering with global biotech firms. LianBio works on various therapies, including those for cancer and rare diseases.

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Mar 27, 2024

Recent annual earnings:

Mar 27, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

Mar 15, 2024
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

03 Jan '24 B of A Securities
Underperform
22 Dec '23 Jefferies
Hold
25 Oct '23 Raymond James
Outperform
14 Oct '22 Raymond James
Outperform
26 Nov '21 Jefferies
Buy
26 Nov '21 Goldman Sachs
Neutral
24 Nov '21 Raymond James
Outperform

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

Why Is LianBio (LIAN) Stock Moving Today?
Why Is LianBio (LIAN) Stock Moving Today?
Why Is LianBio (LIAN) Stock Moving Today?
LIAN
InvestorPlace15 March 2024

LianBio (NASDAQ: LIAN ) stock is moving on Friday and this is likely tied to the company's voluntary delisting of its shares from the Nasdaq Exchange. LianBio announced late last month plans to voluntarily delist shares of LIAN stock.

All You Need to Know About LianBio Sponsored ADR (LIAN) Rating Upgrade to Strong Buy
All You Need to Know About LianBio Sponsored ADR (LIAN) Rating Upgrade to Strong Buy
All You Need to Know About LianBio Sponsored ADR (LIAN) Rating Upgrade to Strong Buy
LIAN
Zacks Investment Research08 November 2023

LianBio Sponsored ADR (LIAN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Why LianBio Stock Is Shooting Through the Roof This Week
Why LianBio Stock Is Shooting Through the Roof This Week
Why LianBio Stock Is Shooting Through the Roof This Week
LIAN
The Motley Fool27 October 2023

LianBio has entered into a major deal with Bristol Myers Squibb. Bristol Myers will pay $350 million for the rights to develop and commercialize LianBio's mavacamten treatment in select Asian countries and territories.

Why Is LianBio (LIAN) Stock Up 130% Today?
Why Is LianBio (LIAN) Stock Up 130% Today?
Why Is LianBio (LIAN) Stock Up 130% Today?
LIAN
InvestorPlace24 October 2023

Shares of LianBio (NASDAQ: LIAN ) — which focuses on “developing and commercializing medicines for cardiovascular, oncology, opthalmology, and inflammatory diseases in China and other Asian countries” — are soaring on Tuesday. Earlier this morning, the company announced a key agreement with Bristol-Myers Squibb (NYSE: BMY ) regarding exclusive rights to a cardiovascular therapeutic.

Why LianBio Stock Is Skyrocketing Today
Why LianBio Stock Is Skyrocketing Today
Why LianBio Stock Is Skyrocketing Today
LIAN
The Motley Fool24 October 2023

LianBio entered into a deal to give Bristol Myers Squibb exclusive rights for mavacemten in China and other Asian markets. The small drugmaker will receive $350 million.

LianBio to Participate in Upcoming Investor Conferences
LianBio to Participate in Upcoming Investor Conferences
LianBio to Participate in Upcoming Investor Conferences
LIAN
GlobeNewsWire01 June 2023

SHANGHAI, China and PRINCETON, N.J., June 01, 2023 (GLOBE NEWSWIRE) -- LianBio (Nasdaq: LIAN), a biotechnology company dedicated to bringing innovative medicines to patients in China and other major Asian markets, today announced that members of the management team will participate in the following upcoming investor conferences:

FAQ

  • What is the primary business of LianBio?
  • What is the ticker symbol for LianBio?
  • Does LianBio pay dividends?
  • What sector is LianBio in?
  • What industry is LianBio in?
  • What country is LianBio based in?
  • When did LianBio go public?
  • Is LianBio in the S&P 500?
  • Is LianBio in the NASDAQ 100?
  • Is LianBio in the Dow Jones?
  • When was LianBio's last earnings report?
  • When does LianBio report earnings?
  • Should I buy LianBio stock now?

What is the primary business of LianBio?

LianBio is a biopharmaceutical company focused on developing and commercializing innovative medicines. It aims to address unmet medical needs in China and other markets by partnering with global biotech firms. LianBio works on various therapies, including those for cancer and rare diseases.

What is the ticker symbol for LianBio?

The ticker symbol for LianBio is NASDAQ:LIAN

Does LianBio pay dividends?

Yes, LianBio pays dividends. The last payment was $4.80, with an ex-dividend date on 15 March 2024

What sector is LianBio in?

LianBio is in the Healthcare sector

What industry is LianBio in?

LianBio is in the Biotechnology industry

What country is LianBio based in?

LianBio is headquartered in United States

When did LianBio go public?

LianBio's initial public offering (IPO) was on 01 November 2021

Is LianBio in the S&P 500?

No, LianBio is not included in the S&P 500 index

Is LianBio in the NASDAQ 100?

No, LianBio is not included in the NASDAQ 100 index

Is LianBio in the Dow Jones?

No, LianBio is not included in the Dow Jones index

When was LianBio's last earnings report?

LianBio's most recent earnings report was on 27 March 2024

When does LianBio report earnings?

The date for LianBio's next earnings report has not been announced yet

Should I buy LianBio stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions